Trichloroacetyl chloride → HCID 178511092, compound
Reaction equation
[CH:1]1([CH:6]([N:11]2[CH:15]=[C:14]([C:16]3[C:17]4[C:25](=[O:26])[CH2:24][NH:23][C:18]=4[N:19]=[C:20]([OH:22])[N:21]=3)[CH:13]=[N:12]2)[CH2:7][C:8]([NH2:10])=O)[CH2:5][CH2:4][CH2:3][CH2:2]1.C(N(CC)CC)C.ClC(Cl)(Cl)C(Cl)=O.CC#N.O>C(Cl)Cl>[CH:1]1([C@H:6]([N:11]2[CH:15]=[C:14]([C:16]3[C:17]4[C:25](=[O:26])[CH2:24][NH:23][C:18]=4[N:19]=[C:20]([OH:22])[N:21]=3)[CH:13]=[N:12]2)[CH2:7][C:8]#[N:10])[CH2:5][CH2:4][CH2:3][CH2:2]1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 3-cyclopentyl-3-[4-(2-hydroxy-5-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanamide (0.006 g, 0.02 mmol) in methylene chloride (0.5 mL) containing triethylamine (20 TL, 0.2 mmol) was added trichloroacetyl chloride (20 TL, 0.2 mmol). When the reaction was complete, preparative HPLC-MS (MeCN/H2O containing 0.15% NH4OH) was used to afford purified product (3 mg, 52%). 1H NMR (400 MHz, d6-DMSO): δ 11.39 (br s, 1H), 9.37 (s, 1H), 8.77 (s, 1H), 8.63 (s, 1H), 4.68-4.59 (m, 1H), 3.94 (s, 2H), 3.19-3.15 (m, 2H), 2.42-2.30 (m, 1H), 1.86-1.75 (m, 1H), 1.69-1.20 (m, 6H), 1.18-1.05 (m, 1H); LCMS (M+H)+: 339.1.
Workup
- customto afford
- custompurified product (3 mg, 52%)
Sources & evidence
- ORD record
- ord-6fc1c005147e441ebccdc4057355899a
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08486902B2
Reaction notes
Loading…